Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$100,000.00
Jun 1, 2011
For-profit organization
508867
508867
Rna Disruption Assay Product Design, Engineering, Clinical Data Analysis & Clinical Prototyping
$843,314.00
Jun 1, 2011
For-profit organization
801915
801915
PlantForm Corporation is a tobacco-plant-based, protein and antibody drug production company and will develop a generic version of breast cancer drug into the pre-clinical/clinical development stage.
$150,000.00
May 1, 2011
Adherence to guidelines on the clinical management of dystocia in British Columbia.
$81,667.00
May 1, 2011
The role of drug transporters in rivaroxaban disposition: molecular determinants of kinetics and clinical drug response
$150,000.00
May 1, 2011
Clinical Applications of Modulating HIF Signaling in Early Mesenchymal Progenitors
$90,000.00
May 1, 2011
Visceral adiposity and related cardiometabolic risk: from epidemiology to a potential therapeutic target in clinical practice
$105,000.00
May 1, 2011
The experiential and cultural dimension of female bisexuality in Canada: What are the clinical implications of being "in-between"?
$72,000.00
May 1, 2011
Clinical and immune correlates of isolated semen HIV shedding
$100,000.00
Apr 1, 2011
Clinical prediction models for critically ill pregnant women: MEOWS and CIPHER
$119,166.00
Apr 1, 2011
Discovery of clinical and metabolic genetic syndromes manifesting as neuropsychiatric disorders